The Smads

International Journal of Biochemistry and Cell Biology

Volumn 31, Issue 11, 1999, Pages 1249-1254

  Hill, Caroline S ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN SERINE THREONINE KINASE; REGULATOR PROTEIN; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CANCER; CELLULAR DISTRIBUTION; COMPLEX FORMATION; FIBROSIS; PROTEIN DEGRADATION; PROTEIN DNA BINDING; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RECEPTOR BINDING; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TRANSCRIPTION REGULATION;

EID: 0032853276     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-2725(99)00093-X     Document Type: Article

References (18)

1. Massagué J. TGF-β signal transduction. Ann. Rev. Biochem. 67:1998;753-791.
2. Macias-Silva M., Hoodless P.A., Tang S.J., Buchwald M., Wrana J.L. Specific activation of Smad1 signaling pathways by the BMP7 type I receptor, ALK2. J. Biol. Chem. 273:1998;25628-25636.
3. Chen Y.G., Massagué J. Smad1 recognition and activation by the ALK1 group of transforming growth factor-β family receptors. J. Biol. Chem. 274:1999;3672-3677.
4. LeSueur J.A., Graff J.M. Spemann organizer activity of Smad10. Development. 126:1999;137-146.
5. Masuyama N., Hanafusa H., Kusakabe M., Shibuya H., Nishida E. Identification of two Smad4 proteins in Xenopus. Their common and distinct properties. J. Biol. Chem. 274:1999;12163-12170.
6. Shi Y., Hata A., Lo R.S., Massagué J., Pavletich N.P. A structural basis for mutational inactivation by the tumour suppressor Smad4. Nature. 388:1997;87-93.
7. Shi Y., Wang Y.F., Jayaraman L., Yang H., Massagué J., Pavletich N.P. Crystal structure of a Smad MH1 domain bound to DNA: insights on DNA binding in TGF-β signaling. Cell. 94:1998;585-594.
8. Kawabata M., Inoue H., Hanyu A., Imamura T., Miyazono K. Smad proteins exist as monomers in vivo and undergo homo- and hetero-oligomerization upon activation by serine/threonine kinase receptors. EMBO J. 17:1998;4056-4065.
9. Chen Y.G., Hata A., Lo R.S., Wotton D., Shi Y., Pavletich N., Massagué J. Determinants of specificity in TGF-β signal transduction. Genes Dev. 12:1998;2144-2152.
10. Whitman M. Smads and early developmental signaling by the TGF-β superfamily. Genes Dev. 12:1998;2445-2462.
11. Derynck R., Zhang Y., Feng X.H. Smads: transcriptional activators of TGF-β responses. Cell. 95:1998;737-740.
12. Ulloa L., Doody J., Massagué J. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature. 397:1999;710-713.
13. Tsukazaki T., Chiang T.A., Davison A.F., Attisano L., Wrana J.L. SARA, a FYVE domain protein that recruits Smad2 to the TGF-β receptor. Cell. 95:1998;779-791.
14. Itoh S., Landstrom M., Hermansson A., Itoh F., Heldin C.H., Heldin N.E., ten Dijke P. Transforming growth factor β1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273:1998;29195-29201.
15. Wotton D., Lo R.S., Lee S., Massagué J. A Smad transcriptional corepressor. Cell. 97:1999;29-39.
16. Yanagisawa J., Yanagi Y., Masuhiro Y., Suzawa M., Watanabe M., Kashiwagi K., Toriyabe T., Kawabata M., Miyazono K., Kato S. Convergence of Transforming Growth Factor-β and Vitamin D Signaling Pathways on SMAD Transcriptional Coactivators. Science. 283:1999;1317-1321.
17. Reiss M. Transforming growth factor-β and cancer: a love-hate relationship? Oncol. Res. 9:1997;447-457.
18. Oft M., Heider K.H., Beug H. TGF-β signaling is necessary for carcinoma cell invasiveness and metastasis. Curr. Biol. 8:1998;1243-1252.